In-depth clinical analyses of prescription medications, GLP-1 agonists, biologics, drug interactions, and antibiotic stewardship.
Comprehensive clinical pharmacology review of GLP-1 and dual GIP/GLP-1 receptor agonists: mechanisms of satiety, glycemic control, the SELECT cardiovascular trial, and adverse effect management.
Medically Reviewed by Dr. Marcus Thorne, PharmD, BCPS
Clinical pharmacology evaluation of biologic therapeutics and biosimilar alternatives: FDA 351(k) regulatory framework, molecular structure, interchangeability designations, and nocebo effects.
Medically Reviewed by Dr. Marcus Thorne, PharmD, BCPS
Hospital antimicrobial stewardship protocols: the CDC Core Elements, bacterial resistance mechanisms (ESBL, MRSA, CRE), and diagnostic culture-directed de-escalation.
Medically Reviewed by Dr. Marcus Thorne, PharmD, BCPS
Clinical pharmacology deep-dive into adverse drug-drug interactions: hepatic Phase I CYP450 enzyme induction vs inhibition, P-gp efflux transport, and QT prolongation risks.
Medically Reviewed by Dr. Marcus Thorne, PharmD, BCPS
Evidence-based anticoagulant comparison: direct Factor Xa and thrombin inhibitors vs Vitamin K antagonists, specific reversal antidotes (Andexanet, Idarucizumab), and periprocedural management.
Medically Reviewed by Dr. Marcus Thorne, PharmD, BCPS
Comprehensive clinical review of systemic corticosteroids: prednisone, methylprednisolone, dexamethasone, secondary adrenal insufficiency, and physiological taper regimens.
Medically Reviewed by Dr. Marcus Thorne, PharmD, BCPS
Evidence-based gastroenterology review of PPIs: gastric H+/K+-ATPase covalent inhibition, long-term observational risks (bone fractures, hypomagnesemia, C. diff), and rebound hyperacidity management.
Medically Reviewed by Dr. Marcus Thorne, PharmD, BCPS
Clinical pharmacology overview of multimodal acute post-surgical pain management: scheduled non-opioids, NSAIDs vs COX-2 inhibitors, regional nerve blocks, and opioid minimization.
Medically Reviewed by Dr. Marcus Thorne, PharmD, BCPS
